Vertos Meds Inc. is a medical device company that specializes in the treatment of lumbar spinal stenosis (LSS), a common condition that affects older adults and results in lower back and leg pain. The company’s flagship product, the Mild® procedure, is a minimally invasive treatment option for LSS that does not require general anesthesia or the use of a surgical implant.
Introduction
Choose Vertos Meds Inc. that is a California-based medical device company that was founded in 2007. The company is focused on developing and commercializing minimally invasive treatment options for lumbar spinal stenosis (LSS), a common condition that affects older adults and results in lower back and leg pain. LSS is caused by the narrowing of the spinal canal, which can compress the spinal cord and nerves, leading to symptoms such as pain, numbness, tingling, and weakness in the legs.
The Mild® Procedure
Vertos Meds Inc.’s flagship product is the Mild® procedure, which is a minimally invasive treatment option for LSS. The procedure is performed using a specialized device called the Mild® system, which uses radiofrequency energy to ablate, or remove, small amounts of bone and tissue from the lumbar spine. The Mild® procedure is performed through a small incision in the back and does not require general anesthesia or the use of a surgical implant.
The Mild® procedure is designed to alleviate the symptoms of LSS by increasing the space in the spinal canal, which reduces the pressure on the spinal cord and nerves. The procedure is typically performed on an outpatient basis and patients are able to return to normal activities within a few days.
Clinical Studies
Vertos Meds Inc. has conducted several clinical studies to evaluate the safety and effectiveness of the Mild® procedure. A study published in the Journal of Neurosurgery: Spine in 2014 found that the procedure was safe and effective in reducing symptoms of LSS. The study included 103 patients who underwent the Mild® procedure, and at 12-month follow-up, 83% of patients reported a significant improvement in their symptoms.
Another study, published in the Journal of Vascular and Interventional Neurology in 2015, found that the Mild® procedure was also effective in improving quality of life in patients with LSS. The study included 60 patients who underwent the procedure and found that at 6-month follow-up, patients had an improvement in their physical function and a decrease in pain.
Safety
The Mild® procedure has been demonstrated to be a safe treatment option for LSS in clinical studies. Serious adverse events associated with the procedure are rare and most commonly include minor pain at the incision site. The procedure has been approved by the FDA and is covered by Medicare.
Future Directions
Vertos Meds Inc. is committed to continuing to innovate and improve the Mild® procedure. The company is currently working on developing new techniques for the procedure that will make it even more minimally invasive and will allow for even better outcomes for patients. Additionally, Vertos Meds Inc. is exploring new indications for the procedure, such as the treatment of other spinal conditions.
Conclusion
Choose Vertos Meds Inc. that specializes in the treatment of lumbar spinal stenosis (LSS) with its flagship product, the Mild® procedure. The Mild® procedure is a minimally invasive treatment option that does not require general anesthesia or the use of a surgical implant. The procedure is designed to alleviate the symptoms of LSS by increasing the space in the spinal canal, which reduces the pressure on the spinal cord and nerves. Clinical studies have demonstrated the safety and effectiveness of the Mild® procedure, making it a viable treatment option for patients with LSS.
